A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy,

Targeting canarypox (CP)-HIV vaccine to dendritic cells (DCs) elicits anti-HIV-1 immune responses in vitro. We conducted a phase I/II clinical trial to evaluate whether adding DC to a CP-HIV vaccine improved virologic control during analytic treatment interruption (ATI) in HIV-1-infected subjects. T...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gandhi, Rajesh T., O'Neill, David, Bosch, Ronald J., Chan, Ellen S., Bucy, R. Pat, Shopis, Janet, Baglyos, Lynn, Adams, Elizabeth, Fox, Lawrence, Purdue, Lynette, Marshak, Ann, Flynn, Theresa, Masih, Reena, Schock, Barbara, Mildvan, Donna, Schlesinger, Sarah J., Marovich, Mary A., Bhardwaj, Nina, Jacobson, Jeffrey M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2820102/
https://ncbi.nlm.nih.gov/pubmed/19450647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.05.016
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi